– 2005. – 108с.
Яичников В.П. Показатели системы гемостаза у больных туберкулезом легких с множественной лекарственной устойчивостью / В.П. Яичников, О.А. Базаленко, С.В. Субочев// XXI Национальный Конгресс по болезням органов дыхания. Сборник трудов Конгресса. Уфа. – 2011. – С.288-289.
-
Яковлева О.А. Генотипический и фенотипический полиморфизм N-ацетилтрансфераз в роли предикторов бронхолегочных заболеваний // Пульмонология. М. – 2003. – №4. – С. 115-121.
-
Ямори Т. Таурин в норме и патологии: результаты экспериментальных и эпидемиологических исследований / Т. Ямори, T. Taguchi, A. Hamada, K. Kunimasa, H. Mori, M. Mori // Российский кардиологический журнал. – 2010. – №6. – С. 64-75.
-
Ярцев Е.И. Таурин. Фармакологические и противолучевые свойства / Е.И. Ярцев, Е.Д. Гольдберг, Ю.А. Колесников // М., – 1975. – 189 c.
-
Acharya M. Comparison of the protective actions of N-acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatotoxicity in the rat / M. Acharya, C.A. Lau-Cam // J. Biomed. Sci. – 2010 Aug 24. – Vol.17. – Suppl. 1. – P.35. doi: 10.1186/1423-0127-17-S1-S35.
-
Alam S.S. Protective role of taurine against genotoxic damage in mice treated with methotrexate and tamoxfine / S.S. Alam, N.A. Hafiz, A.H. Abd El-Rahim // Environ. Toxicol. Pharmacol. – 2011 Jan. – Vol.31. – №1. – P.143-152. doi: 10.1016/j.etap.2010.10.001. Epub. 2010 Oct 28.
-
Aleman M. Mycobacterium tuberculosis – induced activation accelerates apoptosis in peripheral blood neutrophils from patients with active tuberculosis / M. Aleman, A. Garcia, M. Saab // Am. J. Respir. Cell Mol. Biol. – 2002. – Vol.27. – P.583–592.
-
Anderson CD. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts / C.D. Anderson, G. Upadhya, K.D. Conzen, J. Jia, E.M. Brunt, V. Tiriveedhi, Y. Xie, S. Ramachandran, T. Mohanakumar, N.O. Davidson, W.C. Chapman // Liver Transpl. – 2011 Feb. – Vol.17. – №2. – P.189-200. doi: 10.1002/lt.22220.
Andrade R.J. Drug-induced Liver Injury : An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-year Period / R.J. Andrade, M.I. Lucena, M.C. Fernandez // Gastroenterology. – 2005. – Vol.129. – P.512-521.
-
Arend S.M. TNF-alpha blockade and tuberculosis: better look before you leap / S.M. Arend, F.C. Breedveld, J.T. Van Dissel // Neth. О. Med. - 2003. - Vol. 61- №4. - P.lll-119.
-
Azuma J. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial / J. Azuma, A. Sawamura, N. Awata // Clinical. Cardiology. – 1985. – Vol.8. – №5. – P.276–282.
-
Barbeau A. The neuropharmacology of taurine / A. Barbeau, N. Inoue, Y. Tsukada, R.F. Butterworth // Life Sciences. – 1975. – Vol.17. – №5. – P.669–677.
-
Barbeau A. Zinc, taurine, and epilepsy / A. Barbeau, J. Donaldson // Archives of Neurology. – 1974. – Vol. 30. – №1. – P.52–58.
-
Benichou С. Criteria of drug-induced liver disorders. Report of in international consensus meeting // J. Hepatol. – 1990. – Vol.ll. – P.272-276.
Bergeron A. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL10 / A. Bergeron, P. Soler, M. Kambouchner // Eur. Respir. J. – 2003. – V.22. – P.69-76.
-
Bjornsson E. Outcome and Prognostic Markers in Severe Drug-Induced Liver Disease / E. Bjornsson, R. Olisson // Hepathology. – 2005. – Vol.42. – P.481-489.
-
Bouhafs R.K. Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes / R.K. Bouhafs, C. Jarstrand // Free Radic. Res. (England). - Jul. 2002. – Vol.36. - №7. - P.727-734.
-
Brande P. Aging the hepatotoxity of isoniazid and rifampicin in pulmonary tuberculosis // Am. J. Respir. Crit Care Med. - 1995.- Vol. 152.- №5.- P. 1705-1708.
Bruns H. Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study / H. Bruns, I. Watanpour, M.M. Gebhard, C. Flechtenmacher, U. Galli, H. Schulze-Bergkamen, M. Zorn, M.W. Büchler, P. Schemmer // Microcirculation. – 2011 Apr. – Vol.18. – №3. – P.205-13. doi: 10.1111/j.1549-8719.2010.00078.x.
Bu Q. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration / Q. Bu, G. Yan, P. Deng, F. Peng, H. Lin, Y. Xu, Z. Cao, T. Zhou, A. Xue, Y. Wang, X. Cen, Y.L. Zhao // Nanotechnology. – 2010 Mar 26. – Vol.21. – №12. – P.105–125. doi: 10.1088/0957-4484/21/12/125105. Epub 2010 Mar 5.
-
Cascorbi I. Alanine N- acetyltransferase activity in man / I. Cascorbi, J. Brockmoller, P.M. Mrozikiewicz, A. Muller // Drug. metab. rev. – 1999. – Vol.31. – №2. – P.489-502.
Chauncey K.B. The effect of taurine supplementation on patients with type 2 diabetes mellitus / K.B. Chauncey, T.E. Tenner // Advances in Experimental Medicine and Biology. – 2003. – Vol.526. – P.91–96.
Chen W. The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet / W. Chen, K. Matuda, N. Nishimura, H. Yokogoshi // Life. Sci. – 2004. – Vol.74. – №15. – P.1889–1898.
Chen X. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats / X. Chen, B.M. Sebastian, H. Tang, M.M. McMullen, A. Axhemi, D.W. Jacobsen, L.E. Nagy // Hepatology. – 2009 May. – Vol.49. – №5. – P.1554-1562. doi: 10.1002/hep.22811.
-
Cherif H. Effects of taurine on the insulin secretion of rat islets from dams fed a low-protein diet / H. Cherif, B. Reusens, M.T. Ahn // J. Endocrinol. – 1998. – Vol.159. – P.341–48.
Chesney R.W. Taurine and the renal system / R.W. Chesney, X. Han, A.B. Patters // J. Biomed. Sci. – 2010. – Vol.17. – №1. – P.4.
-
Choi D. Taurine depletion by beta-alanine inhibits induction of hepatotoxicity in mice treated acutely with carbon tetrachloride / D. Choi, S.J. Kim, Y. Kwon do, S.Y. Lee, Y.C. Kim // Adv Exp Med Biol. – 2009. – Vol.643. – P.305-11.
Cosma C.L. The secret lives of the pathogenic mycobacteria / C.L. Cosma, D.R. Sherman, L. Ramakrichnan // Annual Rev. Micobiology. – 2003. – Vol.57. – Р.642-676.
-
Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure / N. Henderson, K. Pollock, J. Frewet al. // Gut. 2007. - Vol. 56. N 7. - P. 982-990.
-
Das J. Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1 / J. Das, J. Ghosh, P. Manna, P.C. Sil // Free. Radic. Res. – 2010. – Vol.44. – №3. – P.340–355. doi: 10.3109/10715760903513017.
-
Das J. Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway / J. Das, J. Ghosh, P. Manna, P.C. Sil // PLoS One. – 2010 Sep 7. – Vol.5. – №9. – P.1260–1262. doi: 10.1371/journal.pone.0012602.
Degardin J. Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats / J. Degardin, D. Pain, P. Gondouin, M. Simonutti // Mol. Cell. Neurosci. – 2010 April. – Vol.43. – №4. – P.414–421.
-
Della Corte L. Taurine 4 : Taurine and Excitable Tissues / L. Della Corte // Advances in Experimental Medicine and Biology 483. Plenum Press. New York, 2000.
-
D'Eufemia P. Taurine deficiency in thalassemia majorinduced osteoporosis treated with neridronate / P. D'Eufemia, R. Finocchiaro, M. Celli // Biomed. Pharmacother. – 2010. – Vol.64. – №4. – P.271–74. Epub. 2009 Oct. 23.
El-Batch M. Taurine is more effective than melatonin on cytochrome P450 2E1 and some oxidative stress markers in streptozotocin-induced diabetic rats / M. El-Batch, A.M. Hassan, H.A. Mahmoud // J. Agric. Food Chem. – 2011 May 11. – Vol.59. – №9. – P.4995-5000. doi: 10.1021/jf1049547. Epub. 2011 Mar 22.
-
Erdem A. The effect of taurine on mesenteric blood flow and organ injury in sepsis / A. Erdem, A.M. Sevgili, F. Akbiyik, P. Atilla, N. Cakar, Z.D. Balkanci, A.B. Iskit, M.O. Guc // Amino. Acids. – 2008 Aug. – Vol.35. – №2. – P.403-10. Epub. 2007 Dec 28.
-
Fennessy F.M. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers / F.M. Fennessy, D.S. Moneley, J.H. Wang // Circulation. – 2003. – Vol. 107. – №3. – P.410–415.
-
Flora S.J. Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats / S.J. Flora, S. Chouhan, G.M. Kannan, M. Mittal, H. Swarnkar // Oxid. Med. Cell. Longev. – 2008 Oct-Dec. – Vol.1. – №1. – P.39-45.
Flynn J.L. Immunology of tuberculosis and implications in vaccine development // Tuberculosis. – 2004. – Vol.84. – Р.93-101.
-
Franconi F. Taurine and diabetes – humans and experimental models / F. Franconi, F. Miceli, F. Franconi, M. Miceli, A. Fazzini // Adv. Exp. Med. Biol. – 1996. – Vol.403. – P.579–82.
Fujita T. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension / T. Fujita, K. Ando, H.Y. Noda // Circulation. – 1987. – Vol.75. – №3. – P.525–532.
-
Gardiner S. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice / S. Gardiner, E. Begg // Phar. Rev. 2006. - Vol. 58, N 3. - P. 521590.
Gentile C.L. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease / C.L. Gentile, A.M. Nivala, J.C. Gonzales, K.T. Pfaffenbach, D. Wang, Y. Wei, H. Jiang, D.J. Orlicky, D.R. Petersen, M.J. Pagliassotti, K.N. Maclean // Am. J. Physiol. Regul. Integr. Comp. Physiol. – 2011 Dec. – Vol.301. – №6. – P.1710-1722. doi: 10.1152/ajpregu.00677.2010. Epub 2011 Sep 28.
-
Getiner M. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death / M. Getiner, G. Sener // Toxicol. Appl. Pharmac. – 2005. – Vol.209. – №1. – P.39–50.
-
Ghosh A. Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-kappaB pathway: role of a novel protein / A. Ghosh, P. Sil // Chem. Biol. Interact. 2009. - Vol. 177, N 2. - P. 96-106.
-
Golbidi S. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. / S. Golbidi, M. Badran, I. Laher // Experimental. Diabetes Research. – 2012. – Vol. 2012. – 16 p.
-
Goldberg R. Cytokine and Cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications / R. Goldberg // J. Clin. Endocrinol. Metab. – 2009. – Vol.94. – №9. – P.3171-3182.
Gotsman I. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden / I. Gotsman, A. Stabholz, D. Planer // Isr. Med. Assoc. J. 2008. – Vol.10. – №7. – Р.494-498.
-
Guan X. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation / X. Guan, G. Dei-Anane, R. Liang, M.L. Gross, A. Nickkholgh, M. Kern, J. Ludwig, M. Zeier, M.W. Büchler, J. Schmidt, P. Schemmer // J. Surg. Res. – 2008 May 1. – Vol.146. – №1. – P.127-34. Epub. 2007 Jul 25.
Guidtlines for the Management of Multidrug-Resistant tuberculosis. WHO 2000.
-
Hales C.N. Type 2 (non-insulindependent) diabetes mellitus: the thrifty phenotype hypothesis / C.N. Hales, D.J.P. Barker // Diabetologia. – 1992. – Vol.35. – P.595–601.
-
Han J. Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism / J. Han, J.H. Bae, S.Y. Kim // Am. J. Physiol. Endocr. Metab. – 2004. – Vol.287. – №5. – P.1008–1018.
-
Hanley J.A. The meaning and use of area under a receiver operating characteristic (ROC) curve / J.A. Hanley, B.J. McNeil // Radiology. – 1982. – V.143, № 1. – P. 29-36.
-
Harada H. Diagnosis and treatment of pulmonary tuberculosis complicated with chronic liver disease / H. Harada, S. Murai, H. Kojima // Nippon-Rinsho. – 1998. – №56. – P.3212-3216.
Harada H. Taurine deficiency and doxorubicin: interactionwith the cardiac sarcolemmal calcium pump / H. Harada, B.J. Cusack, R.D. Olson, W. Stroo. // Biochem. Pharm. – 1980. – Vol.39. – P.745–751. doi: 10.1016/0006-2952(90)90154-D.
-
Harris T. B. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly / Harris T. B., Ferrucci I., Traxy R. P. et al. // Am. J. Med. – 1999. – 106: 506-512.
-
Hayes K.C. Taurine deficiency syndrome in cats / K.C. Hayes, E.A. Trautwein // Vet. Clin. North. Am. Small. Anim. Pract. – 1989. – Vol.19. – №3. – P.403–13.
-
Hayes K.C. Taurine modulates platelet aggregation in cats and humans / K.C. Hayes, A. Pronczuk, A.E. Addesa // Am. J. Clin. Nutr. – 1989. – Vol.49. – P.1211–1216.
Henderson J.M., Gastrointestinal pathophysiology. – пер. с англ. – M.СПб. – пер. с англ. – с.165 - 195.
-
Hest N.A. Severe hepatotoxic side-effects related to treatment lateut tuberculosis infection with two months of rifampin and pyrazinamide in the Netherlands / N.A. Hest, M. Trompenaars, H. Baars // Int. I. Lung Dis. – 2002. – Vol.6. – №10. – suppl.1. – P.126-127.
-
Histologically proven isoniazid hepatoxicity in complicated tuberculosis / A. Semfke, C. Wackernagel, H. Vier et al. // Ther. Adv. Resp. Dis. 2009. -Vol. 3, N 4. - P. 159-162.
Hohenester S. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes / S. Hohenester, L.M. Wenniger, C.C. Paulusma, S.J. van Vliet, D.M. Jefferson, R.P. Elferink, U. Beuers // Hepatology. – 2012 Jan. – Vol.55. – №1. – P.173-83. doi: 10.1002/hep.24691.
-
Horowitz G.L. Reference Intervals: Practical Aspect / G.L. Horowitz, N.K. Hollenberg, S.W. Graves // JIFCC. -2008. – 19:2.
-
Hu Y.H. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients / Y.H. Hu, C.L. Lin, Y.W. Huang, P.E. Liu, D.F. Hwang // Amino. Acids. – 2008 Aug. – Vol.35. – №2. – P.469-73. Epub. 2007 Aug 10.
-
Huang D.Y. Impaired ability to increase / D.Y. Huang, K.M. Boini, P.A. Lang, F. Grahammer, Т. Ito // Journal of Biomedical Science. – 2010. – Vol.17(Suppl 1):S20 water excretion in mice lacking the taurine transporter gene TAUT. Pflugers. Arch. – 2006. – Vol.451. – P.668–677.
-
Huang YS. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis / Y.S. Huang, H.D. Chern, W.J. Su // Hepathology. – 2003. – Vol.37. – P.924-30.
Hwang S.L. A prospective clinical study of izoniazid-rifampicinpyrazinamide - induced liver injery in an area endemic for hepatitis В // Gastroenterol. Hepatol. – 1997. – Vol.12. – №1. – P 87-91.
Ito T. Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice / T. Ito, S. Muraoka, K. Takahashi, Y. Fujio, S.W. Schaffer, J. Azuma // Adv. Expt. Med. Biol. – 2009. – Vol.643. – P.65–73.
Ito T. Involvement of transcriptional factor TonEBP in the regulation of the taurine transporter in the cardiomyocyte / T. Ito, Y. Fujio, S.W. Schaffer, J. Azuma // Adv. Expt. Med. Biol. – 2009. – Vol.643. – P.523–532.
-
Jaeschke H. Intracellular signaling mechanisms of acetaminophen-induced liver cell death / H. Jaeschke, M. Bajt // Toxicol. Sci. 2006. - Vol. 89, N 1. -P. 31-41.
Jakubzick C. Therapeutic attenuation of pulmonary fibrosis via targeting of ИЛ-4- and IL-13-responsive cells / C. Jakubzick, E.S. Choi, B.H. Joshi //J. Immunol. – 2003. – Vol. 171. – P.2684-2693.
-
Jeevanandam M. Effect of major trauma on plasma free amino acid concentrations in geriatric patients / M. Jeevanandam, D.H. Young, L. Ramias, W.R. Schiller // Am. J. Clin. Nutr. – 1990. – Vol.51. – №6. – P.1040–1945.
Jenny Nilsson-Ohman Tumor Necrosis Factor-alpha Does Not Mediate Diabetes-Induced Vascular Inflammation in Mice / Jenny Nilsson-Ohman // Arterioscler. Thromb. Vasc. Biol. – 2009. – Vol.29. – Р.1465-1470.
-
Kaplowitz N. Drug-induced liver disease / N. Kaplowitz, L.D. DeLeve // Informa Healthcare. – 2007. – P.808.
Kaplowitz N. Drug-Induced liver disorders : implications for drug development and regulation // Drug Saf. – 2001. – Vol.24. – P.483-490.
-
Kaufman S.E. Protection against tuberculosis: cytokines, T-cells and macrophages //Ann. Rheum. Dis. – 2002. – Vol.61. – P.1154-1158.
-
Kim J. An Overview of Drug-Induced Liver Disease // US Pharm. – 2005. – Vol.11. – P.10-21.
-
Kim K.S. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes / Kim KS, H. Oh, J.Y. Kim, B.G. Lee // Exp. Mol. Med. – 2012. – Vol.44. – №11. – P.665-673.
-
Kim S.J. Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation / S.J. Kim, Y.S. Jung, Y. Kwon do, Y.C. Kim // Biochem. Biophys. Res. Commun. – 2008 Apr 18. – Vol.368. – №4. – P.893-8. doi: 10.1016/j.bbrc.2008.02.003. Epub 2008 Feb 11.
-
Kirino Y. Codonspecific translational defect caused by wobble modification deficiency in mutant tRNA from a human mitochondrial disease / Y. Kirino, T. Yasukawa, S. Ohta // Proc. Natl. Acad. Sci. USA. – 2004. – Vol. 101. – №1. – P.5070–5075.
-
Kirino Y. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease / Y. Kirino, Y.I. Goto, Y. Campos, J. Arenas, T. Suzuki // Proc. Natl. Acad. Sci. USA. – 2005. – Vol. 102. – P.7127–7132.
-
Kittleson M.D. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration / M.D. Kittleson, B. Keene, P.D. Pion, C.G. Loyer // In. J. Vet. Intern. Med. – 1997. – Vol.11. – №4. – P.204–11.
-
Kwon do Y. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats / Y. Kwon do, Y.S. Jung, S.J. Kim, H.K. Park, J.H. Park, Y.C. Kim // J. Nutr. – 2009 Jan. – Vol.139. – №1. – P.63-8. doi: 10.3945/jn.108.094771. Epub 2008 Dec 3.
Lazarevic V. CD8 cells in tuberculosis / V. Lazarevic, J. Flynn // Am. J. Respir. Crit. Care Med. – 2002. – Vol.166. – P.1116-1121.
-
Lee A.Y. Contributions of polyolpathway to oxidative stress in diabetic cataract / A.Y. Lee, S.S. Chung // FASEB. J. – 1999. – Vol.13. – P.23–30.
Lei R. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity / R. Lei, C. Wu, B. Yang, H. Ma, C. Shi, Q.Wang, Q. Wang, Y. Yuan, M. Liao // Toxicol. Appl. Pharmacol. – 2008 Oct 15. – Vol.232. – №2. – P.292-301. doi: 10.1016/j.taap.2008.06.026. Epub 2008 Jul 26.
Liang Q. Nephrotoxicity study of Aristolochia fangchi in rats by metabonomics / Q. Liang, C. Ni, M. Xie, Q. Zhang, Y.X. Zhang, X.Z. Yan, M.J. Yang, S.Q. Peng, Y.Z.Zhang // Zhong Xi Yi Jie He Xue Bao. – 2009 Aug. – Vol.7. – №8. – P.746-752. doi: 10.3736/jcim20090808.
Liang Y.J. Metabonomic responses in rat urine following subacute exposure to propoxur / Y.J. Liang, H.P. Wang, L. Yang, W. Li, Y.J. Wu // Int. J. Toxicol. – 2012 Jun. – Vol.31. – №3. – P.287-293. doi: 10.1177/1091581812441030. Epub 2012 May 1.
-
Liao Y. Metabonomics profile of urine from rats administrated with different treatment period of isoniazid / Y. Liao, S.Q. Peng, X.Z. Yan, L.S. Zhang // Zhongguo Yi Xue Ke Xue Yuan Xue Bao. – 2007 Dec. – Vol.29. – №6. – P.730-7.
-
Liao Y. Selection of agents for prevention of cisplatin-induced hepatotoxicity / Y. Liao, X. Lu, C. Lu, G. Li, Y. Jin, H. Tang // Pharmacol. Res. – 2008 Feb. – Vol.57. – №2. – P.125-31. doi: 10.1016/j.phrs.2008.01.001. Epub. 2008 Jan 6.
-
Liu Y. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy / Y. Liu, R. Huang, L. Liu, J. Peng, B. Xiao, J. Yang, Z. Miao, H. Huang // J. Pharm. Biomed. Anal. – 2010 May 1. – Vol.52. – №1. – P.136-141. doi: 10.1016/j.jpba.2009.12.026. Epub 2009 Dec 29.
Lu C. NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats / C. Lu, Y. Wang, Z. Sheng, G. Liu, Fu, J. Zhao, J. Zhao, X. Yan, B. Zhu, S. Peng // Toxicol. Appl. Pharmacol. 2010 Nov 1. – Vol.248. – №3. – P.178-184. doi: 10.1016/j.taap.2010.07.020. Epub 2010 Aug 5.
Luo N. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis / N. Luo, J. Liu, B. Chung // DIABETES. – 2010. – Vоl. 59, april. – P.791-799.
Marion T.L. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes / T.L. Marion, C.H. Perry, R.L. St. Claire 3rd, W. Yue, K.L. Brouwer // Toxicol Sci. – 2011 Apr. – Vol.120. – №2. – P.371-80. doi: 10.1093/toxsci/kfr014. Epub 2011 Jan 24.
-
Mazzanti L. Altered cellular Ca2+ and Na+ transport in diabetes mellitus / L. Mazzanti, R.A. Rabini, E. Faloila // Diabetes. – 1990. – Vol.39. – P.850–54.
-
Mc Glynn K.A. Izoniazid prophylaxis in hepatitis В carriers / K.A. Mc Glynn, E.D. Lustbader, R.G. Sharrar, E.C. Murphy, W.T. London // Am. Rev. Respir. Dis.-1986. – Vol.l34. – №4. – P.666-668.
-
McManus M.L. Regulation of cell vulume in health and disease / M.L. McManus, K.B.C. Hurchwell, K.S. Trange // N. Engl. J. Med. – 1995. – Vol.333. – P.1260–1266.
-
Mercurio F. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappa B activation / F. Mercurio, H. Zhu, B.W. Murray // Science. – 1997. – Vol.278. – Р.860–66.
-
Murakami S. Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet / Y. Murakami, Y. Kondo-Ohta, K. Tomisawa // Life. Sci. – 1999. – Vol.64. – P.83–91.
-
Nagayama N. Secular increase in the incidence rate of drug-induced hepatitis due to antituberculosis chemotherapy including isoniazid and rifampicin / N. Nagayama, M. Masuda, M. Baba // Kekkaku. – 2003. – Vol.78. – P.339-46.
Nakaya Y. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes / Y. Nakaya, A. Minami, N. Harada // Am. J. Clin. Nutr. – 2000. – Vol.71. – P.54–58.
North R., Yu-Jin Jung Immunity to tuberculosis // Annual rev. immunology. – 2004. – Vol.22. – P.599-623.
Novotny M.J. Echocardiographic Evidence for Myocardial Failure Induced by Taurine Deficiency in Domestic Cats / M.J. Novotny, P.M. Hogan, G. Flannigan // Can. J. Vet. Res. – 1994. – Vol.58. – P.6–12.
-
Oprescu A.I. Free Fatty Acid – Induced Reduction in Glucose-Stimulated Insulin Secretion / A.I. Oprescu, G. Bikopoulos, A. Naassan // Diabetes. – 2007. – Vol.56. – P.2927–2937.
-
Ortis F. Cytokines interleukin-1 and tumor necrosis factor-regulate different ranscriptional and alternative splicing networks in primary – cells / F. Ortis, N. Naamane, D. Flamez // DIABETES. – 2010. – V. 59, february. – P.358-364.
Ozden S. Methiocarb-induced oxidative damage following subacute exposure and the protective effects of vitamin E and taurine in rats / S. Ozden, B. Catalgol, S. Gezginci-Oktayoglu, P. Arda-Pirincci, S. Bolkent, B. Alpertunga // Food Chem. Toxicol. – 2009 Jul. – Vol.47. – №7. – P.1676-1684. doi: 10.1016/j.fct.2009.04.018. Epub. 2009 Apr 24.
-
Pacheco G.S. Brain creatine kinase activity is inhibited after hepatic failure induced by carbon tetrachloride or acetaminophen / G.S. Pacheco, J.P. Panatto, D.A. Fagundes, G. Scaini, C. Bassani, I.C. Jeremias, G.T. Rezin, L. Constantino, F. Dal-Pizzol, E.L. Streck // Metab. Brain. Dis. – 2009 Sep. – Vol.24. – №3. – P.383-394. doi: 10.1007/s11011-009-9143-8. Epub. 2009 Aug 18.
-
Pan Lei Effects of antituberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatits В virus / Lei Pan, Zhan-Sheng Jia, En Qing Fu, Guang-Yu Li // World J.Gastroenterol. – 2005. – Vol.11. – №16. – P.2518-2521.
-
Pasantes-Morales H. Taurine and brain development: trophic or cytoprotective actions? / H. Pasantes-Morales, R. Hernandez-Benitez // Neurochem. Res. – 2010. – Vol.35. – №12. – P.1939–1943. Epub. 2010 Sep. 15.
-
Peters U. Glutathiont-S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin / U. Peters, S. Preisler-Adams, A. Hebebeisen. // Anticancer Drugs. – 2000. – Vol.11. – 8. – P.639-643.
Pfaffenbach K.T. Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death / K.T. Pfaffenbach, C.L. Gentile, A.M. Nivala, D. Wang, Y. Wei, M.J. Pagliassotti // Am. J. Physiol. Endocrinol. Metab. – 2010 May. – Vol.298. – №5. – P.1027-1035. doi: 10.1152/ajpendo.00642.2009. Epub 2010 Feb 16.
-
Pion P.D. Response of cats with dilated cardiomyopathy to taurine supplementation / P.D. Pion, M.D. Kittleson, W.P. Thomas, L.A. Delellis, Q.R. Rogers // J. Am. Vet. Med. Assoc. – 1992 Jul. 15. – Vol.201. – №2. – P.275–84.
-
Poitout V. Minireview: secondary β-cell failure in type 2 diabetes – a convergence of glucotoxicity and lipotoxicity / V. Poitout, R.P. Robertson // Endocrinology. – 2002. – Vol.143. – P.339–42.
-
Pradhan A. Alterations in bronchoalveolar lavage constituents, oxidant/antioxidant status, and lung histology following intratracheal instillation of respirable suspended particulate matter / A. Pradhan, M. Waseem, S. Dogra // J. Environ. Pathol. Toxicol. Oncol. (United States). – 2005. – Vol.24. – №1. – P.29-32.
-
Sahin M.A. Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia? / M.A. Sahin, O. Yucel, A. Guler // J. Cardiothorac. Surg. – 2011. – Vol.6. – P.31–37.
-
Sanderson SL. Taurine and carnitine in canine cardiomyopathy / S.L. Sanderson // Vet. Clin. North. Am. Small. Anim. Pract. – 2006. – Vol.36. – №6. – P.1325–1343.
-
Schaffer S.W. Role of antioxidant activity of taurine in diabetes / S.W. Schaffer, J. Azuma, M. Mozaffari // Can. J. Physiol. Pharmacol. – 2009. – Vol. 87. – P.91–99.
-
Schindler G. Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury / G. Schindler, M. Kincius, R. Liang, J. Backhaus, M. Zorn, C. Flechtenmacher, M.M. Gebhard, M.W. Büchler, P. Schemmer // Microcirculation. – 2009 Oct. – Vol.16. – №7. – P.593-602. doi: 10.1080/10739680903110779. Epub 2009 Jul 22.
-
Schnackenberg L.K. Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies / L.K. Schnackenberg, M. Chen, J. Sun // Toxicol. Appl. Pharmacol. – 2009 Feb 15. – Vol.235. – №1. – P.25-32. doi: 10.1016/j.taap.2008.11.015. Epub 2008 Dec 6.
-
Seghieri G. Taurine in women with a history of gestational diabetes / G. Seghieri, F. Tesi, L. Bianchi, A. Loizzo, G. Saccomanni, G. Ghirlanda, R. Anichini, F. Franconi // Diabetes Res. Clin. Pract. – 2006.
-
Sehgal A. Free oxygen radicals and immune profile in newborns with lung diseases / A. Sehgal, A. Saili, R.P. Gupta // J. Trop. Pediatr. (England). – Dec.2000. – Vol.46. – №6. – P.335-337.
-
Sgro C. Incidence of drug-induced hepatic injuries: a French population-based study / C. Sgro, F. Clinard, K. Ouazir // Hepatology. – 2002. – №.36. – P.451-455.
Shimada T. Potential implications for monitoring serum bile acid profiles in circulation with serum proteome for carbon tetrachloride-induced liver injury/regeneration model in mice / T. Shimada, T. Nakanishi, A. Toyama, S. Yamauchi, A. Kanzaki, H. Fujiwake, T.A. Sato, M. Ikegawa // J. Proteome. Res. – 2010 Sep 3. – Vol.9. – №9. – P.4490-4500. doi: 10.1021/pr1002388.
-
Singh R.B. Effect of taurine and coenzyme Q10 in patientswith acute myocardial infarction / R.B. Singh, K. Kartikey, A.S. Charu // Advances in Experimental Medicine and Biology. – 2003. – Vol.526. – P.41–48.
-
Srivastava S. Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM) / S. Srivastava, C.S. Joshi, P.P. Sethi // Thromb. Res. – 1994. – Vol.76. – P.451–61.
Strieter R.M., KeaneM.P. Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis//J. Clin. Invest. – 2004. – Vol.114. – P.165-168.
Sturman J.A. Effects of deficiency of vitamin B6 on transsulfuration / J.A. Sturman, P.A. Cohen, G.E. Gaullaull // Biochem Ann NYAcad Sci 1986. – Vol.477. – P.196–213.
-
Sturman J.A. Taurine in Development / J.A. Sturman // Physiol. Rev. – 1993. – Vol.73. – №1.
-
Sun K. Effect of taurine on IRAK4 and NF-kappa B in Kupffer cells from rat liver grafts after ischemia-reperfusion injury / K. Sun, Y. Chen, S.Y. Liang, Z.J. Liu, W.Y. Liao, Z.B. Ou, B. Tu, J.P. Gong // Am. J. Surg. 2012. Sep. – Vol.204. – №3. – P.389-95. doi: 10.1016/j.amjsurg.2011.10.020. Epub 2012 Jul 6.
Sunahara S. Genetical and geographic studies on izoniazid inactivasion / S. Sunahara, M. Urano, M. Ogawa // Science. – Vol.134. – 1961. – P.1530-1531.
-
Suzuki T. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases / T. Suzuki, T. Wada, K. Saigo, K. Watanabe //. Embo. J. – 2002. – Vol. 21. – P.6581–6589.
-
Takashi I. Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice / I. Takashi, O. Shohei, T. Mika // J. Biomed. Sci. – 2010. – Vol.17. – №1. – P.20.
-
Tasci I. Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury / I. Tasci, N. Mas, M.R. Mas, M. Tuncer, B. Comert // World J. Gastroenterol. – 2008 Aug 21. – Vol.14. – №31. – P.4897-4902.
-
Tennant F. Hepatitis С, B, D and A: contrasting Features and liver function abnormalities in herion addicts // Journal of Addictive Diseases. – 2001. – Vol.20. – №1. – P.9-17.
-
Tiedemann F. Einige neue Bestandtheile der Galle des Ochsen (1827) / F. Tiedemann, L. Gmelin // Annalen der Physik. – Vol. 85. – №2. – Р. 326–37. DOI:10.1002/andp.18270850214.
-
Tsuchiya T. Dendritic cell involvement in pulmonary granuloma formation elicited by bacillus Calmette–Guerin in rats / Tsuchiya T., Chida K., Suda T. // Am. J. Respir. Crit. Care Med. – 2002. – Vol.165. – P.1640–1646.
-
Turktas H. Hepatotoxity of antituberculosis therapy (rifampicin, isoniazid and pirazinamide or viral hepatitis) / H. Turktas, M. Unsal, N. Tulek, O. Oruc // Tub. and Lung dis. – 1994. – Vol.75. – P.58-60.
-
Ulrich-Merzenich G. Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins / G. Ulrich-Merzenich, H. Zeitler, H. Vetter // Eur. J. Nutr. – 2007. – Vol.46. – №8. – P.431–38.
-
Wallace D.R. Decreased plasma taurine in aged rats / D.R. Wallace, R. Dawson // Gerontology. 1990. – Vol.36. – №1. – P.19–27.
-
Warskulat U. Chronic liver disease is triggered by taurine transporter knockout in the mouse / U. Warskulat, U. Borsch, U. Warskulat, E. Borsch, Reinehr R. Reinehr // Faseb. J. – 2006. – Vol.20. – P.574–76.
-
Warskulat U. Phenotype of the taurine transporter knockout mouse / U. Warskulat, B. Heller-Stilb, E. Oermann, K. Zilles, H. Haas, F. Lang, D. Haussinger // Methods Enzymol. – 2007. – Vol.428. – P.439–58.
-
Wei L. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum / L. Wei, P. Liao, H. Wu, X. Li, F. Pei, W. Li, Y. Wu // Toxicol. Appl. Pharmacol. – 2008 Mar 15. – Vol.227. – №3. – P.417-29. doi: 10.1016/j.taap.2007.11.015. Epub. 2007 Nov 28.
-
Wei S. Taurine attenuates liver injury by downregulating phosphorylated p38 MAPK of Kupffer cells in rats with severe acute pancreatitis / S. Wei, Q. Huang, J. Li, Z. Liu, H. You, Y. Chen, J. Gong // Inflammation. – 2012 Apr. – Vol.35. – №2. – P.690-701. doi: 10.1007/s10753-011-9362-0.
-
Welles E.G. Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats / E.G. Welles, M.K. Boudreaux, J.W. Tyler // Am. J. Vet. Res. – 1993. – Vol.54. – №8. – P.1235–43.
-
Wharton B.A. Low plasma taurine and later neurodevelopment / B.A. Wharton, R. Morley, E.B. Isaacs, T.J. Cole, A. Lucas // Archives of Disease in Childhood Fetal and Neonatal Edition. – 2004. – Vol.89.
-
WHO. The World Health Report. 1999.
-
Wilde M.I. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification / M.I. Wilde, A.J. Wagstaff // Drugs. 1997. – Vol.53. – 6. – P.1038–1053.
Worden J.A. A comparison by species, age and sex of cysteine sulfinate decarboxylase activity and taurine concentration in liver and brain of animals / J.A. Worden, M.H. Stipanuk // Comp. Biochem. Physiol. – 1985. – Vol. 82. – №2. – P.233–239.
-
Xu Y. Evaluation on hepatotoxicity caused by Dioscorea bulbifera based on analysis of bile acids / Y. Xu, C.C. Chen, L. Yang, J.M. Wang, L.L. Ji, Z.T. Wang, Z.B. Hu // Yao Xue Bao. – 2011 Jan. – Vol.46. – №1. – P.39-44.
Yamada H. Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine γ-lyase, an animal model of cystathioninuria / H. Yamada, N. Akahoshi, S. Kamata, Y. Hagiya, T. Hishiki, Y. Nagahata, T. Matsuura, N. Takano, M. Mori, Y. Ishizaki, T. Izumi, Y. Kumagai, T. Kasahara, M. Suematsu, I. Ishii // Free Radic. Biol. Med. – 2012 May 1. – Vol.52. – №9. – P.1716-1726. doi: 10.1016/j.freeradbiomed.2012.02.033. Epub 2012 Mar 3.
-
Yamori Y. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies / Y. Yamori, T. Taguchi, A. Hamada, K. Kunimasa, H. Mori, M. Mori // From 17th International Meeting of Taurine Fort Lauderdale FL, USA. 14–19 December. 2009. – J. Biomed. Sci. – 2010. – Vol.17. – №1. – P.6–9.
-
Yamori Y. WHO-Cardiovascular Disease and Alimentary Comprarison (CARDIAC) Study Group. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study / Y. Yamori, L. Liu, Ikeda K, A. Miura, S. Mizushima, T. Miki, Y. Nara // Hypertens. Res. – 2001. – Vol.24. – №4. – P.453–57.
-
Zar J. H. Biostatistical analysis / Prentice-Hall, Englewood Cliffs. – N.J., 1984.
-
Zentay Z. Cytosolic Ca profile of resting and thrombin stimulated platelets from black women with NIDDM / Z. Zentay, M. Raguwanshi, A. Reddi // J. Diabetes. Complications. – 1995. – Vol.9. – P.74–80.
-
Zhang F. Protective effects of taurine against endotoxin-induced acute liver injury after hepatic ischemia reperfusion / F. Zhang, Y. Mao, H. Qiao // Amino. Acids. – 2010 Jan. – Vol.38. – №1. – P.237-245. doi: 10.1007/s00726-009-0233-z. Epub 2009 Mar 5.
-
Zhang Y. Effect of bile duct ligation on bile acid composition in mouse serum and liver / Y. Zhang, J.Y. Hong, C.E. Rockwell // Liver Int. – 2012 Jan. – Vol.32. – №1. – P.58-69. doi: 10.1111/j.1478-3231.2011.02662.x. 2011 Oct 17.
Zhuo L. Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats / L. Zhuo, M. Liao, L. Zheng // Biol. Pharm. Bull. 2012. – Vol.35. – №10. – P.1802-1810.
|
